---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-058675"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T09:22:12.904010+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pacira proposes $250M convertible note offering due 2029; up to $50M share repurchase

## Summary
- Proposed offering of $250M aggregate principal of Convertible Senior Notes due 2029, with initial purchasers' option for additional $37.5M.
- Proceeds to repurchase portion of outstanding 0.750% 2025 Notes, fund capped call transactions, and repurchase up to $50M of common stock.
- Capped call transactions expected to reduce dilution upon conversion and offset cash payments in excess of principal amount.
- Entered First Amendment to Credit Agreement to permit $150M share repurchase program and the proposed note offering.

## SEC filing metadata
- accession: 0001104659-24-058675
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000110465924058675/0001104659-24-058675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000110465924058675/tm2413714d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-058675
- JSON: https://secwatch.observer/filing/0001104659-24-058675.json
- Plain text: https://secwatch.observer/filing/0001104659-24-058675.txt

## Key facts
- Material Agreements
  Pacira BioSciences, Inc. amended First TLA Amendment with JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders (effective 2024-05-08).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders
  - Effective: 2024-05-08
  source text: On May 8, 2024, Pacira BioSciences, Inc. (the “Company”), JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders entered into a first amendment (the “First TLA Amendment”) to the Credit Agreement, dated as of March 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000110465924058675/0001104659-24-058675-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.